Faron Pharmaceuticals Oy
FARN.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £254 | £219,230 | £77,536 | £241,018 |
| - Cash | £13,532 | £9,503 | £29,979 | £6,875 |
| + Debt | £22,408 | £12,113 | £12,722 | £13,111 |
| Enterprise Value | £9,130 | £221,840 | £60,279 | £247,254 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | -£6 | -£7 | -£11 | -£16 |
| % Margin | – | – | – | – |
| Net Income | -£10 | -£12 | -£14 | -£17 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.09 | -0.054 | -0.1 | -0.13 |
| % Growth | -67.1% | 45.9% | 23.1% | – |
| Operating Cash Flow | -£5 | -£14 | -£9 | -£11 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£5 | -£14 | -£9 | -£11 |